| DC Field | Value | Language |
|---|
| dc.contributor.author | Yakovleva, E. E. | - |
| dc.contributor.author | Kamalova, M. T. | - |
| dc.contributor.author | Yakovleva, V. G. | - |
| dc.contributor.author | Brusina, M. A. | - |
| dc.contributor.author | Bychkov, E. R. | - |
| dc.date.accessioned | 2026-03-19T07:16:21Z | - |
| dc.date.available | 2026-03-19T07:16:21Z | - |
| dc.date.issued | 2025 | - |
| dc.identifier.citation | Investigation of imidazole-4,5-dicarboxylic acid derivatives activity on visceral pain in mice / E.E. Yakovleva, M.T. Kamalova, V.G. Yakovleva [et al.] // Research Results in Pharmacology. - 2025. - Vol.11, №4.-P. 199-204. - Doi: 10.18413/rrpharmacology.11.773. - Refer.: p. 203-204. | ru |
| dc.identifier.uri | http://dspace.bsuedu.ru/handle/123456789/66373 | - |
| dc.description.abstract | Experimental studies on rodents have shown that mGluR1 receptor inhibitors demonstrate antinociceptive potential in acute pain models. New ligands of the glutamate NMDA-receptor complex are imidazole-4,5-dicarboxylic acid derivatives, which conformational rigidity allows increasing selectivity interaction and decreasing a number of side effects with the implementiation a high analgesic potential | ru |
| dc.language.iso | en | ru |
| dc.subject | medicine | ru |
| dc.subject | pharmacology | ru |
| dc.subject | glutamate | ru |
| dc.subject | NMDA-receptor | ru |
| dc.subject | antagonists | ru |
| dc.subject | imidazole-4,5-dicarboxylic acid derivatives | ru |
| dc.subject | analgesic effect | ru |
| dc.subject | visceral pain | ru |
| dc.subject | mice | ru |
| dc.title | Investigation of imidazole-4,5-dicarboxylic acid derivatives activity on visceral pain in mice | ru |
| dc.type | Article | ru |
| Appears in Collections: | Vol. 11, № 4
|
